但是由于重症肌无力疾病本身的复杂性，疾病的个体差异和自然进展差异很大，因此术后一些病人的病情常有波动，在手术后无效、恶化、甚至死亡。
However, there were still some patients who showed no change or deteriorated and even died soon after surgery, for the complexity of MG in pathogenesis and the individual difference of patients.
目的观察血浆置换联合小剂量激素治疗重症肌无力的临床疗效及安全性。
Objective To explore the therapeutic effects of blood plasma replacement and small dose hormone on myasthenia gravis (MG).
方法对81例重症肌无力患者的死因进行回顾性分析。
Methods: To do retrospective analysis of death reasons in 81 MG patients.
应用推荐